Abstract
The HELLP (Hemolysis, Elevated Liver enzyme, and Low Platelet) syndrome requires close monitoring of rapid changes in hemostasis. A bedside viscoelastic test – Sonoclot – was used together with coagulation, liver and hemolysis laboratory analyses in three parturients with the HELLP syndrome up to 10 days postpartum. Principal component analysis (PCA) was used to reduce the dimensionality of this multivariate problem and to visualize this process in a two-dimensional plot. It was possible to follow changes in these variables over time and to show how they changed in relation to 10 typical healthy parturients with normal laboratory and Sonoclot values as well as 20 simulated patients with hypo- or hypercoagubility. The effects of emergency delivery, correction of low plasma-antithrombin with plasma and antithrombin factor concentrate, plasma exchange and individualized dosages of low molecular weight heparin to counteract postpartum Sonoclot detected hypercoagulation were evaluated. The efficiency of each treatment strategy was visualized in the PCA plot by movement towards an area with normocoagulation. In conclusion, PCA of viscoelastic and laboratory coagulation analysis data facilitated the detection of both hypo- and hypercoagulative events and represents an alternative way to evaluate treatment strategies in patients with complex coagulative disorders, like the HELLP syndrome.
Similar content being viewed by others
References
Sibai BM, Ramadan MK, Usta I, et al, Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000–1063.
Fish R, The HELLP syndrome: Case report and review of the literature. J Emerg Med 1993; 11: 169–174.
Stevenson JT, Graham DJ, Hepatic hemorrhage and the HELLP syndrome: A surgeon’s perspective. Am Surgeon 1995; 61: 756–760.
Barton JR, Riely CA, Adamec TA, et al, Hepatic histopathology condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992; 167: 1538-1543.
Steer PL, Krantz HB, Thromboelastography and Sonoclot analysis in the healthy parturient. J Clin Anesth 1993; 5: 419–424.
Whitta RK, Cox DJ, Mallet SV, Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 1995; 74: 464–468.
Wong CA, Liu S, Glassenberg R, Comparison of thrombelastography with common coagulation tests in preeclamptic and healthy parturients. Reg Anesth 1995; 20: 521–527.
Orlikowski CEP, Rocke DA, Murray WB et al, Thrombelastography changes in pre-eclampsia and eclampsia. Br J Anesth 1996; 77: 157–161.
Steer PL, Finley BE, Blumenthal LA, Abruptio placentae and disseminated intravascular coagulation: Use of thrombelastography and sonoclot analysis. Int J Obstet Anesth 1994; 3: 229-233.
Kjellberg U, Hellgren M, Sonoclot signature during normal pregnancy. Int Care Med 2000; 26: 206–211.
Meherg L, Jeffrey B, Riley BA, Wolk DR, Do sonoclot coagulation parameters correlate with thromboelastograph parameters. J Extra-Corp Tech 1993; 24: 145–151.
Chatfield C, Introduction to multivariate analysis. London: Chapman & Hall, 1992.
Liszka-Hackzell J, Ekback G, Analysis of the information content in sonoclot data and reconstruction of coagulation test variables. J Med Syst 2002; 26: 1–8.
Romeo M, Burden F, Quinn M, Wood B, McNaughton D, Infrared microspectroscopy and artificial neural networks in the diagnosis of cervical cancer. Cell Mol Biol 1998; 44(1): 179–187.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liszka-Hackzell, J.J., Schött, U. Presentation of Laboratory and Sonoclot Variables Using Principal Component Analysis: Identification of Hypo- and Hypercoagulation in the Hellp Syndrome. J Clin Monit Comput 18, 247–252 (2004). https://doi.org/10.1007/s10877-005-9046-0
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10877-005-9046-0